Copyright Reports & Markets. All rights reserved.

Global Gastro Esophageal Reflux Disease Drug and Devices Market Research Report 2019

Buy now

Table of Contents

    Executive Summary

      1 Gastro Esophageal Reflux Disease Drug and Devices Market Overview

      • 1.1 Product Overview and Scope of Gastro Esophageal Reflux Disease Drug and Devices
      • 1.2 Gastro Esophageal Reflux Disease Drug and Devices Segment by Type
        • 1.2.1 Global Gastro Esophageal Reflux Disease Drug and Devices Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Medigus Ultrasonic Surgical Endostapler
        • 1.2.3 LINX Management System
        • 1.2.4 Stretta Therapy
        • 1.2.5 Bravo Reflux Testing System
        • 1.2.6 Digitrapper Reflux Testing System
        • 1.2.7 Others
      • 1.3 Gastro Esophageal Reflux Disease Drug and Devices Segment by Application
        • 1.3.1 Gastro Esophageal Reflux Disease Drug and Devices Consumption Comparison by Application (2014-2025)
        • 1.3.2 Hospitals
        • 1.3.3 Clinics
        • 1.3.4 Others
      • 1.3 Global Gastro Esophageal Reflux Disease Drug and Devices Market by Region
        • 1.3.1 Global Gastro Esophageal Reflux Disease Drug and Devices Market Size Region
        • 1.3.2 North America Status and Prospect (2014-2025)
        • 1.3.3 Europe Status and Prospect (2014-2025)
        • 1.3.4 China Status and Prospect (2014-2025)
        • 1.3.5 Japan Status and Prospect (2014-2025)
        • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
        • 1.3.7 India Status and Prospect (2014-2025)
      • 1.4 Global Gastro Esophageal Reflux Disease Drug and Devices Market Size
        • 1.4.1 Global Gastro Esophageal Reflux Disease Drug and Devices Revenue (2014-2025)
        • 1.4.2 Global Gastro Esophageal Reflux Disease Drug and Devices Production (2014-2025)

      2 Global Gastro Esophageal Reflux Disease Drug and Devices Market Competition by Manufacturers

      • 2.1 Global Gastro Esophageal Reflux Disease Drug and Devices Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Gastro Esophageal Reflux Disease Drug and Devices Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Gastro Esophageal Reflux Disease Drug and Devices Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Gastro Esophageal Reflux Disease Drug and Devices Production Sites, Area Served, Product Types
      • 2.5 Gastro Esophageal Reflux Disease Drug and Devices Market Competitive Situation and Trends
        • 2.5.1 Gastro Esophageal Reflux Disease Drug and Devices Market Concentration Rate
        • 2.5.2 Gastro Esophageal Reflux Disease Drug and Devices Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Gastro Esophageal Reflux Disease Drug and Devices Production Market Share by Regions

      • 3.1 Global Gastro Esophageal Reflux Disease Drug and Devices Production Market Share by Regions
      • 3.2 Global Gastro Esophageal Reflux Disease Drug and Devices Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Gastro Esophageal Reflux Disease Drug and Devices Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Gastro Esophageal Reflux Disease Drug and Devices Production
        • 3.4.1 North America Gastro Esophageal Reflux Disease Drug and Devices Production Growth Rate (2014-2019)
        • 3.4.2 North America Gastro Esophageal Reflux Disease Drug and Devices Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Gastro Esophageal Reflux Disease Drug and Devices Production
        • 3.5.1 Europe Gastro Esophageal Reflux Disease Drug and Devices Production Growth Rate (2014-2019)
        • 3.5.2 Europe Gastro Esophageal Reflux Disease Drug and Devices Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Gastro Esophageal Reflux Disease Drug and Devices Production (2014-2019)
        • 3.6.1 China Gastro Esophageal Reflux Disease Drug and Devices Production Growth Rate (2014-2019)
        • 3.6.2 China Gastro Esophageal Reflux Disease Drug and Devices Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Gastro Esophageal Reflux Disease Drug and Devices Production (2014-2019)
        • 3.7.1 Japan Gastro Esophageal Reflux Disease Drug and Devices Production Growth Rate (2014-2019)
        • 3.7.2 Japan Gastro Esophageal Reflux Disease Drug and Devices Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Gastro Esophageal Reflux Disease Drug and Devices Consumption by Regions

      • 4.1 Global Gastro Esophageal Reflux Disease Drug and Devices Consumption by Regions
      • 4.2 North America Gastro Esophageal Reflux Disease Drug and Devices Consumption (2014-2019)
      • 4.3 Europe Gastro Esophageal Reflux Disease Drug and Devices Consumption (2014-2019)
      • 4.4 China Gastro Esophageal Reflux Disease Drug and Devices Consumption (2014-2019)
      • 4.5 Japan Gastro Esophageal Reflux Disease Drug and Devices Consumption (2014-2019)

      5 Global Gastro Esophageal Reflux Disease Drug and Devices Production, Revenue, Price Trend by Type

      • 5.1 Global Gastro Esophageal Reflux Disease Drug and Devices Production Market Share by Type (2014-2019)
      • 5.2 Global Gastro Esophageal Reflux Disease Drug and Devices Revenue Market Share by Type (2014-2019)
      • 5.3 Global Gastro Esophageal Reflux Disease Drug and Devices Price by Type (2014-2019)
      • 5.4 Global Gastro Esophageal Reflux Disease Drug and Devices Production Growth by Type (2014-2019)

      6 Global Gastro Esophageal Reflux Disease Drug and Devices Market Analysis by Applications

      • 6.1 Global Gastro Esophageal Reflux Disease Drug and Devices Consumption Market Share by Application (2014-2019)
      • 6.2 Global Gastro Esophageal Reflux Disease Drug and Devices Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Gastro Esophageal Reflux Disease Drug and Devices Business

      • 7.1 AstraZeneca PLC
        • 7.1.1 AstraZeneca PLC Gastro Esophageal Reflux Disease Drug and Devices Production Sites and Area Served
        • 7.1.2 Gastro Esophageal Reflux Disease Drug and Devices Product Introduction, Application and Specification
        • 7.1.3 AstraZeneca PLC Gastro Esophageal Reflux Disease Drug and Devices Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Pfizer Inc.
        • 7.2.1 Pfizer Inc. Gastro Esophageal Reflux Disease Drug and Devices Production Sites and Area Served
        • 7.2.2 Gastro Esophageal Reflux Disease Drug and Devices Product Introduction, Application and Specification
        • 7.2.3 Pfizer Inc. Gastro Esophageal Reflux Disease Drug and Devices Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Johnson & Johnson
        • 7.3.1 Johnson & Johnson Gastro Esophageal Reflux Disease Drug and Devices Production Sites and Area Served
        • 7.3.2 Gastro Esophageal Reflux Disease Drug and Devices Product Introduction, Application and Specification
        • 7.3.3 Johnson & Johnson Gastro Esophageal Reflux Disease Drug and Devices Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Novartis AG
        • 7.4.1 Novartis AG Gastro Esophageal Reflux Disease Drug and Devices Production Sites and Area Served
        • 7.4.2 Gastro Esophageal Reflux Disease Drug and Devices Product Introduction, Application and Specification
        • 7.4.3 Novartis AG Gastro Esophageal Reflux Disease Drug and Devices Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 GlaxoSmithKline Plc
        • 7.5.1 GlaxoSmithKline Plc Gastro Esophageal Reflux Disease Drug and Devices Production Sites and Area Served
        • 7.5.2 Gastro Esophageal Reflux Disease Drug and Devices Product Introduction, Application and Specification
        • 7.5.3 GlaxoSmithKline Plc Gastro Esophageal Reflux Disease Drug and Devices Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Merck & CO., Inc.
        • 7.6.1 Merck & CO., Inc. Gastro Esophageal Reflux Disease Drug and Devices Production Sites and Area Served
        • 7.6.2 Gastro Esophageal Reflux Disease Drug and Devices Product Introduction, Application and Specification
        • 7.6.3 Merck & CO., Inc. Gastro Esophageal Reflux Disease Drug and Devices Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Takeda Pharmaceutical Company Limited
        • 7.7.1 Takeda Pharmaceutical Company Limited Gastro Esophageal Reflux Disease Drug and Devices Production Sites and Area Served
        • 7.7.2 Gastro Esophageal Reflux Disease Drug and Devices Product Introduction, Application and Specification
        • 7.7.3 Takeda Pharmaceutical Company Limited Gastro Esophageal Reflux Disease Drug and Devices Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Boston Scientific Corporation
        • 7.8.1 Boston Scientific Corporation Gastro Esophageal Reflux Disease Drug and Devices Production Sites and Area Served
        • 7.8.2 Gastro Esophageal Reflux Disease Drug and Devices Product Introduction, Application and Specification
        • 7.8.3 Boston Scientific Corporation Gastro Esophageal Reflux Disease Drug and Devices Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Ironwood Pharmaceuticals, Inc.
        • 7.9.1 Ironwood Pharmaceuticals, Inc. Gastro Esophageal Reflux Disease Drug and Devices Production Sites and Area Served
        • 7.9.2 Gastro Esophageal Reflux Disease Drug and Devices Product Introduction, Application and Specification
        • 7.9.3 Ironwood Pharmaceuticals, Inc. Gastro Esophageal Reflux Disease Drug and Devices Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Valeant Pharmaceuticals International, Inc.
        • 7.10.1 Valeant Pharmaceuticals International, Inc. Gastro Esophageal Reflux Disease Drug and Devices Production Sites and Area Served
        • 7.10.2 Gastro Esophageal Reflux Disease Drug and Devices Product Introduction, Application and Specification
        • 7.10.3 Valeant Pharmaceuticals International, Inc. Gastro Esophageal Reflux Disease Drug and Devices Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served
      • 7.11 Cempra Inc.
      • 7.12 Medtronic Inc.
      • 7.13 Medigus Ltd.
      • 7.14 Teva Pharmaceuticals Industries Limited.
      • 7.15 EndoGastric Solutions Inc.
      • 7.16 EndoStim Inc.
      • 7.17 Jeil pharmaceutical Co. Ltd.
      • 7.18 Mederi Therapeutics Inc.
      • 7.19 Torax Medical

      8 Gastro Esophageal Reflux Disease Drug and Devices Manufacturing Cost Analysis

      • 8.1 Gastro Esophageal Reflux Disease Drug and Devices Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Gastro Esophageal Reflux Disease Drug and Devices
      • 8.4 Gastro Esophageal Reflux Disease Drug and Devices Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Gastro Esophageal Reflux Disease Drug and Devices Distributors List
      • 9.3 Gastro Esophageal Reflux Disease Drug and Devices Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Gastro Esophageal Reflux Disease Drug and Devices Market Forecast

      • 11.1 Global Gastro Esophageal Reflux Disease Drug and Devices Production, Revenue Forecast
        • 11.1.1 Global Gastro Esophageal Reflux Disease Drug and Devices Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Gastro Esophageal Reflux Disease Drug and Devices Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Gastro Esophageal Reflux Disease Drug and Devices Price and Trend Forecast (2019-2025)
      • 11.2 Global Gastro Esophageal Reflux Disease Drug and Devices Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Gastro Esophageal Reflux Disease Drug and Devices Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Gastro Esophageal Reflux Disease Drug and Devices Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Gastro Esophageal Reflux Disease Drug and Devices Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Gastro Esophageal Reflux Disease Drug and Devices Production, Revenue Forecast (2019-2025)
      • 11.3 Global Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast (2019-2025)
        • 11.3.2 Europe Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast (2019-2025)
        • 11.3.3 China Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast (2019-2025)
        • 11.3.4 Japan Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast (2019-2025)
      • 11.4 Global Gastro Esophageal Reflux Disease Drug and Devices Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global Gastro Esophageal Reflux Disease Drug and Devices market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report focuses on Gastro Esophageal Reflux Disease Drug and Devices volume and value at global level, regional level and company level. From a global perspective, this report represents overall Gastro Esophageal Reflux Disease Drug and Devices market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        AstraZeneca PLC
        Pfizer Inc.
        Johnson & Johnson
        Novartis AG
        GlaxoSmithKline Plc
        Merck & CO., Inc.
        Takeda Pharmaceutical Company Limited
        Boston Scientific Corporation
        Ironwood Pharmaceuticals, Inc.
        Valeant Pharmaceuticals International, Inc.
        Cempra Inc.
        Medtronic Inc.
        Medigus Ltd.
        Teva Pharmaceuticals Industries Limited.
        EndoGastric Solutions Inc.
        EndoStim Inc.
        Jeil pharmaceutical Co. Ltd.
        Mederi Therapeutics Inc.
        Torax Medical

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Medigus Ultrasonic Surgical Endostapler
        LINX Management System
        Stretta Therapy
        Bravo Reflux Testing System
        Digitrapper Reflux Testing System
        Others

        Segment by Application
        Hospitals
        Clinics
        Others

        Buy now